CLGM
ELV icon

Capitolis Liquid Global Markets’s Elevance Health ELV Stock Holding History

Capitolis Liquid Global Markets’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238M Buy
614,190
+549,152
+844% +$204M 1.03% 26
2026
Q1 		$19M Sell
65,038
-9,962
-13% -$3.27M 0.12% 134
2025
Q4 		$26.3M Buy
75,000
+37,000
+97% +$12.5M 0.16% 100
2025
Q3 		$12.3M Hold
38,000
– – 0.1% 125
2025
Q2 		$14.8M Sell
38,000
-7,000
-16% -$2.82M 0.11% 124
2025
Q1 		$19.6M Hold
45,000
– – 0.17% 85
2024
Q4 		$16.6M Buy
+45,000
New +$18.8M 0.16% 68

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capitolis Liquid Global Markets's ELV Position: Q2 2026 in Review

Capitolis Liquid Global Markets increased its Elevance Health (ELV) stake by 844% in Q2 2026, buying an estimated $204M and bringing the position to 614,190 shares worth $238M. The position accounts for 1.03% of the portfolio, ranked #26.

Capitolis Liquid Global Markets first reported a position in ELV in Q4 2024 and has held it in 7 quarters since. 1,606 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capitolis Liquid Global Markets held 614,190 shares of Elevance Health worth $238M as of Q2 2026.
  • Capitolis Liquid Global Markets bought 549,152 Elevance Health shares in Q2 2026, an estimated $204M.
  • Elevance Health made up 1.03% of Capitolis Liquid Global Markets's portfolio in Q2 2026, its #26 holding.
  • Capitolis Liquid Global Markets first reported a position in Elevance Health in Q4 2024 and has held it in 7 quarters since.
  • 1,606 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capitolis Liquid Global Markets's 13F filing for Q2 2026, filed 13 Aug 2026.